Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: A double-blind, placebo controlled trial

Alternative Therapies in Health and Medicine

Volumn 9, Issue 4, 2003, Pages 38-48

  Lappin, Martha S ^a   Lawrie, Fraser Wilson ^b   Richards, Todd L ^c   Kramer, Eric D ^d  

^a Ener Med Devmt (N America) Inc   (United States)

^b Ener Med Devmt (N America) Inc   (Canada)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Department of Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BLADDER FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROMAGNETIC FIELD; ELECTROMAGNETIC THERAPY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PHYSICAL DISABILITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SPASTICITY; STUDENT T TEST; TREATMENT OUTCOME; UNITED STATES;

ADULT; DOUBLE-BLIND METHOD; ELECTROMAGNETIC FIELDS; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; URINARY INCONTINENCE;

EID: 0038354707     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil. 1984 Mar;65(3):135-8.
2. Kraft GH, Freal JE, Coryell JK. Disability, disease duration, and rehabilitation service needs in multiple sclerosis: patient perspectives. Arch Phys Med Rehabil. 1986 Mar;67(3):164-8.
3. Fisk JD. Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994 Feb;21(1):9-14.
4. Bergamaschi R, Romanin A, Versino M, Poli R, Cosi V. Clinical aspects of fatigue in multiple sclerosis. Funct Neurol. 1997;12:247-251.
5. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988;45(4):435-7.
6. Murray TJ, Amantadine therapy for fatigue in multiple sclerosis. Can J Neurol Sci. 1985 Aug;12(3):251-4.
7. Rivto P, Fischer J, Miller D, Andrews H, Paty D, LaRocca N. Multiple Sclerosis Quality of Life Inventory: A User's Manual. New York: National Mutiple Sclerosis Society;1997.
8. Canadian MS Research Group. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. Can J Neurol Sci. 1987;14:273-278.
9. Schwartz CE, Coulthard-Morris L, Zeng Q. Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehabil. 1996;77(2):165-70.
10. Edgley K, Sullivan M, Dehoux E. A survey of multiple sclerosis II: Determinants of employment status. Can J Rehabil. 1991;4:127-132.
11. Thompson AJ. Symptomatic management and rehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001;71 Suppl 2:ii22-7.
12. Krupp LB, Coyle PK, Doscher C. Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology. 1995 Nov;45(11):1956-61.
13. Weinshenker BG, Penman m, Bass B, Ebers GC, Rice GPA. A double-blind, randomized controlled trial of pemoline in fatigue associated with multiple sclerosis. Arch Neurol. 1992;45:1104-1106.
14. Goodin DS. Survey of multiple sclerosis in northern California. Northern California MS Study Group. Mult Scler. 1999 Apr;5(2):78-88.
15. Bassett CA. THerapeutic uses of electric and magnetic fields in orthopedics. In Carpenter D, Ayrapetyan S, eds. Biological Effects of Electric and Magnetic Fields: Beneficial and Harmful Effects. New York: Academic Press;1994:14-48.
16. Trock DH, Bollet AJ, Dyer RH Jr, Fielding LP, Miner WK, Markoll R. A double-blind trial of the clinical effects of pulsed electromagnetic fields in osteoarthritis. J Rheumatol. 1993 Mar;20(3):456-60.
17. Trock DH, Bollet AJ, Markoll R. The effect of pulsed electromagnetic fields in the treatment of osteoarthritis of the knee and cervical spine. Report of randomized, double blind, placebo controlled trials. J Rheumatol. 1994 Oct;21(10):1903-11.
18. George MS, Wasserman EM, Williams WA, Callahan A, Ketter TA, Basset P, Hallett M, Post RM. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depressed state. Neuroreport. 1995;6:1853-1856.
19. George MS, Wasserman EM, Kimbrell TA, Little JT, Williams WE, Danileson AL, Greenberg BD, Hallett M, Post RM. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: A placebo controlled crossover trial. Am J Psychiatry. 1997;154:1752-1756.
20. Pascual-Leone A, Rubio B, Pallardo F, Catala MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 1996 Jul 27;348(9022):233-7.
21. Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. Int J Neurosci. 1992 0ct;66(34):237-50. Review.
22. Sandyk R. Long term beneficial effects of weak electromagnetic fields in lutiple sclerosis. Int J Neurosci. 1995;83:45-57.
23. Gueso A. Pulsing electromagnetic field therapy of multiple sclerosis by the Gyuling-Bordacs device: Double-blind, cross-over and open studies. J Bioelectricity. 1987;6:23-35.
24. Richards TL, Lappin MS, Lawrie FW, Stegbauer KC. Bioelectromagnetic applications for multiple sclerosis. Phy Med Rehab Clin. 1998;9(3):659-674.
25. Richards TL, Lappin MS, Acosta-Urquidi J, Kraft GH, Heide AC, Lawrie FW, Merrill TE, Melton GB, Cunningham CA. Double-blind study of pulsing magnetic field effects on multiple sclerosis. J Altern Complement Med. 1997 Spring;3(1):21-9.
26. Schwartz CE, Vollmer T, Zeng Q. New outcome measures for MS clinical research: the Symptom Inventory and the Performance Scales [Abstract]. Neurology. 1996;46 supplement: A321.
27. Schwartz CE, Vollmer T, Lee H. Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Neurology. 1999 Jan 1;52(1):63-70.
28. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227-31.
29. Acosta-Urquidi J, Richards T. Bioelectric correlates of an energetic healing session. Towards a Science of Consciousness. Tucson, Ariz; 1998.
30. Stewart A, Ware JE Jr, Brook RH. The meaning of health: understanding functional limitations. Med Care. 1977 Nov;15(11):939-52.
31. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444-52.
32. Lappin MS. Evaluation of a Pulsed Electromagnetic Therapy (Enermed) on Multiple Sclerosis (MS) Patient Symptoms and Quality of Life: Final Report submitted to the Multiple Sclerosis Association of America. Vancouver, BC: Energy Medicine Developments; 1998.
33. George MS, Wasserman EM, Post RM. Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century. J Neuropsychiatry Clin Neurosci. 1996;8:373-382.
34. Kirkcaldie MT, Pridmore SA, Pascual-Leone A. Transcranial magnetic stimulation as therapy for depression and other disorders. Aust N Z J Psychiatry. 1997 Apr;31(2):264-72.
35. Nielsen JF, Sinkjaer T, Jakobsen J. Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study. Mult Scler. 1996 Dec;2(5):227-32.
36. Monks J. Experiencing symptoms in chronic illness: fatigue in multiple sclerosis. Int Disabil Stud. 1989 Apr-Jun;11(2):78-83.
37. Ford H, Trigwell P, Johnson M. The nature of fatigue in multiple sclerosis. J Psychosom Res. 1998 Jul;45(1 Spec No):33-8.
38. Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-1b in MS: results of an open label trial. Neurology. 1996 Feb;46(2):552-4.
39. Heide AC, Kraft GH, Slimp JC, Gardner JC, Posse S, Serafini S, Bowen JD, Richards TL. Cerebral N-acetylaspartate is low in patients with multiple sclerosis and abnormal visual evoked potentials. AJNR Am J Neuroradiol. 1998 Jun-Jul;19(6):1047-54.
40. Barkhatova VP, Zavalishin IA, Askarova LSh, Shavratskii VKh, Demina EG. Changes in neurotransmitters in multiple sclerosis. Neurosci Behav Physiol. 1998 Jul-Aug;28(4):341-4.
41. Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, Hennerici M. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol. 1998 Jan;55(1):66-72.
42. Kumpfel T, Then Bergh F, Friess E, Uhr M, Yassouridis A, Trenkwalder C, Holsboer F. Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology. 1999 Dec;70(6):431-8.
43. Then Bergh F, Kumpfel T, Trenkwalder C, Rupprecht R, Holsboer F. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology. 1999 Sep 11;53(4):772-7.
44. Lai H. Carino MA, Horita A, Guy AW. Effects of a 60 Hz magnetic field on central cholinergic systems of the rat. Bioelectromagnetics. 1993;14(1):5-15.
45. Monks J. Experiencing symptoms in chronic illness: fatigue in multiple sclerosis. Int Disabil Stud. 1989 Apr-Jun;11(2):78-83.
46. Seegal RF, Wolpow JR, Dowman R. Chronic exposure of primates to 60 Hz electric and magnetic fields: II Neurochemical effects. Bioelctromagnetics. 1989;10:289-301.
47. Levine RL, Dooley JK, Bluni TD. Related Articles, Links Magnetic field effects on spatial discrimination and melatonin levels in mice. Physiol Behav. 1995 Sep;58(3):535-7.
48. Reiter RJ. Electromagnetic fields and melatonin production. Biomed Pharmacother. 1993;47(10):439-44.
49. Reiter RJ. Static and extremely low frequency electromagnetic field exposure: reported effects on the circadian production of melatonin. J Cell Biochem. 1993 Apr;51(4):394-403.
50. Reiter RJ, Tan DX, Poeggeler B, Kavet R. Inconsistent suppression of nocturnal pineal melatonin synthesis and serum melatonin levels in rats exposed to pulsed DC magnetic fields. Bioelectromagnetics. 1998;19(5):318-29.
51. Yaga K, Reiter RJ, Manchester LC, Nieves H, Sun JH, Chen LD. Pineal sensitivity to pulsed static magnetic fields changes during the photoperiod. Brain Res Bull. 1993;30(1-2):153-6.
52. Sandyk R. I. Role of the pineal gland in multiple sclerosis: a hypothesis. J Altern Complement Med. 1997 Fall;3(3):267-90. Review.
53. Bassett CA. Beneficial effects of electromagnetic fields. J Cell Biochem. 1993 Apr;51(4):387-93.
54. Goodman R, Hendersen AS. Effects of electric and magnetic fields on transcription. In: Carpenter DO, Ayrapetyan S, eds. Biological Effects of Electric and Magnetic Fields: Beneficial and Harmful Effects. New York: Academic press; 1994:157-176.
55. Rusovan A, Kanje M, Mild KH. The stimulatory effect of magnetic fields on regeneration of the rat sciatic nerve is frequency dependent. Exp Neurol. 1992 Jul;117(1):81-4.
56. Speer AM, Kimbrell TA, Wassermann EM, D Repella J, Willis MW, Herscovitch P, Post RM. Opposite effects of high and tow frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000 Dec 15;48(12):1133-41.
57. Baker-Price LA, Persinger MA. Weak, but complex pulsed magnetic fields may reduce depression following traumatic brain injury. Percept Mot Skills. 1996 Oct;83(2):491-8.
58. Fleischmann A, Sternheim A, Etgen AM, Li C, Grisaru N, Belmaker RH. Transcranial magnetic stimulation downregulates beta-adrenoreceptors in rat cortex. J Neurol Transm. 1996;103(11):1361-6.
59. Ben-Shachar D, Belmaker RH, Grisaru N, Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. J Neurol Transm. 1997;104(2-3):191-7.
60. Keck ME, Engelmann M, Muller MB, et al. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J Psychiatr Res. 2000 Jul-Oct;34(4-5):265-76.
61. Keck ME, Welt T, Post A, et al. Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology. 2001 Apr;24(4):337-40.
62. George MS, Wassermann EM, Williams WA, Steppel J, Pascual-Leone A, Basser P, Hallett M, Post RM. Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):172-80.
63. Evers S, Hengst K, Pecuch PW. The impact of repetitive transcranial magnetic stimulation on pituitary hormone levels and cortisol in healthy subjects. J Affect Disord. 2001 Sep;66(1):83-8.
64. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality oflife in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler. 2001 Oct;7(5):340-4.
65. Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, Janardhan V, Dubey N, Kinkel PR. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler. 2000 Jun;6(3):181-5.
66. Kroencke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler. 2000 Apr;6(2):131-6.
67. Colon E, Hommes OR, de Weerd JP. Relation between EEG and disability scores in multiple sclerosis. Clin Neurol Neurosurg. 1981;83(3):163-8.
68. Kassubek J, Soros P, Kober H, Stippich C, Vieth JB. Focal slow and beta brain activity in patients with multiple sclerosis revealed by magnetoencephalography. Brain Topogr. 1999 Spring;11(3):193-200.
69. Leocani L, Locatelli T, Martinelli V, Rovaris M, Falautano M, Filippi M, Magnani G, Coral G. Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings. J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):192-8.
70. Brau H, Ulrich G. Electroencephalographic vigilance dynamics in multiple sclerosis during an acute episode and after remission. Eur Arch Psychiatry Neurol Sci. 1990;239(5):320-4.
71. Richards TL, Acosta-Urquidi J, Merrill TE, Kraft GH, Lappin MS, Lawrie FW. Consortium of Multiple Sclerosis Center Abstracts - Pulsing magnetic field treatment effects on brain electrical activity in multiple sclerosis. Multiple Sclerosis. 1997;3:206.
72. Bell GB, Marino AA, Chesson AL. Alterations in brain electrical activity caused by magnetic fields: detecting the detection process. Electroencephalogr Clin Neurophysiol. 1992 Dec;83(6):389-97.
73. Bell G, Marino A, Chesson A, Struve F. Electrical states in the rabbit brain can be altered by light and electromagnetic fields. Brain Res. 1992 Jan 20;570(1-2):307-15.
74. Heusser K, Tellschaft D, Thoss F. Influence of an alternating 3 Hz magnetic field with an induction of 0.1 millitesla on chosen parameters of the human occipital EEG. Neurosci Lett. 1997 Dec 19;239(2-3):57-60.
75. Reiser H, Dimpfel W, Schober F. The influence of electromagnetic fields on human brain activity. Eur J Med Res. 1995 Oct 16;1(1):27-32.
76. Chaudhuri A, Behan PO. Fatigue and basal ganglia. J Nurol Sci. 2000 Oct 1;179(S 1-2);34-42.
77. Leocani L, Colombo B, Magnani G, Martinelli-Boneschi F, Cursi M, Rossi P, Martinelli V, Comi G. Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement - EEG evidence. Neuroimage. 2001 Jun;13(6 Pt 1):1186-92.
78. Sheean GL, Murray NM, Rothwell JC, Miller DH, Thompson AJ. An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain. 1997 Feb;120(Pt 2):299-315.
79. Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, Comi G. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage. 2002 Mar;15(3):559-67.